SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Wednesday reported a loss of $3.8 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 5 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
The molecular diagnostic company posted revenue of $80.3 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $75.6 million.
For the year, the company reported a loss of $36.6 million, or 51 cents per share. Revenue was reported as $296.5 million.
Veracyte expects full-year revenue in the range of $325 million to $335 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.